Free Trial

Cencora (COR) Competitors

Cencora logo
$291.66 -1.27 (-0.43%)
As of 10:52 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

COR vs. MCK, CAH, HSIC, PDCO, OMI, HLF, NUS, COSM, HWH, and MEDS

Should you be buying Cencora stock or one of its competitors? The main competitors of Cencora include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO), Owens & Minor (OMI), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and TRxADE HEALTH (MEDS).

Cencora vs.

McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, community ranking, media sentiment, institutional ownership, dividends, valuation and risk.

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$359.05B0.25$3.00B$25.8327.84
Cencora$638.56M88.86$1.51B$8.6233.96

McKesson received 228 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.26% of users gave McKesson an outperform vote while only 65.27% of users gave Cencora an outperform vote.

CompanyUnderperformOutperform
McKessonOutperform Votes
978
74.26%
Underperform Votes
339
25.74%
CencoraOutperform Votes
750
65.27%
Underperform Votes
399
34.73%

McKesson has a beta of 0.53, suggesting that its share price is 47% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500.

McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. McKesson pays out 11.0% of its earnings in the form of a dividend. Cencora pays out 25.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years and Cencora has increased its dividend for 15 consecutive years.

85.1% of McKesson shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.1% of McKesson shares are held by insiders. Comparatively, 10.8% of Cencora shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, McKesson had 6 more articles in the media than Cencora. MarketBeat recorded 39 mentions for McKesson and 33 mentions for Cencora. McKesson's average media sentiment score of 1.51 beat Cencora's score of 1.50 indicating that McKesson is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
36 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Cencora
26 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive

McKesson presently has a consensus target price of $686.69, suggesting a potential downside of 4.50%. Cencora has a consensus target price of $301.18, suggesting a potential upside of 2.87%. Given Cencora's higher probable upside, analysts plainly believe Cencora is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.87
Cencora
0 Sell rating(s)
2 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.80

McKesson has a net margin of 0.82% compared to Cencora's net margin of 0.46%. Cencora's return on equity of 328.62% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson0.82% -181.26% 5.34%
Cencora 0.46%328.62%4.23%

Summary

McKesson beats Cencora on 14 of the 22 factors compared between the two stocks.

Get Cencora News Delivered to You Automatically

Sign up to receive the latest news and ratings for COR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COR vs. The Competition

MetricCencoraDrugs, proprietaries, & sundries IndustryMedical SectorNYSE Exchange
Market Cap$56.72B$24.59B$5.43B$19.70B
Dividend Yield0.76%1.34%5.22%3.84%
P/E Ratio41.6514.0126.8335.13
Price / Sales88.8610.87392.3534.12
Price / Cash12.2512.9538.2517.51
Price / Book156.5633.266.874.78
Net Income$1.51B$872.92M$3.22B$1.02B
7 Day Performance4.67%1.10%6.76%1.62%
1 Month Performance4.07%13.57%13.66%13.00%
1 Year Performance34.85%-7.94%18.27%5.59%

Cencora Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
COR
Cencora
4.5787 of 5 stars
$291.66
-0.4%
$301.18
+3.3%
+32.4%$56.55B$638.56M41.5042,000Positive News
MCK
McKesson
4.4375 of 5 stars
$686.92
-0.9%
$686.69
0.0%
+27.5%$86.09B$344.58B31.4575,000Positive News
Analyst Downgrade
High Trading Volume
CAH
Cardinal Health
4.693 of 5 stars
$148.50
+0.2%
$146.43
-1.4%
+57.1%$35.44B$222.29B27.7146,500Positive News
HSIC
Henry Schein
2.7416 of 5 stars
$70.47
+2.7%
$79.30
+12.5%
-0.5%$8.58B$12.67B29.0022,000Positive News
PDCO
Patterson Companies
1.4107 of 5 stars
$31.33
flat
$26.57
-15.2%
N/A$2.77B$6.51B18.327,700News Coverage
OMI
Owens & Minor
4.8223 of 5 stars
$7.16
+2.1%
$12.50
+74.7%
-59.4%$552.76M$10.70B-11.0122,500Positive News
Gap Down
HLF
Herbalife
4.5562 of 5 stars
$7.07
+5.0%
$11.50
+62.7%
-36.7%$719.86M$4.95B2.8410,100Positive News
NUS
Nu Skin Enterprises
3.1795 of 5 stars
$7.47
+9.1%
$6.88
-7.9%
-43.7%$371.18M$1.68B-2.5313,400Positive News
COSM
Cosmos Health
2.1538 of 5 stars
$0.43
+2.2%
N/A-34.5%$11.72M$54.43M-0.18100News Coverage
Earnings Report
Gap Down
HWH
HWH International
N/A$1.17
+6.4%
N/A-76.6%$7.58M$1.25M0.00N/AEarnings Report
Gap Down
MEDS
TRxADE HEALTH
N/A$0.92
-1.6%
N/A-83.5%$1.29M$7.45M0.0050Gap Up

Related Companies and Tools


This page (NYSE:COR) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners